Brief Title
Transcriptional and Immine Parameters of Response to Belinumab
Protocol ID
NCT04570306
Brief Summary
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Belimumab
Sponsor: Biomedical Research Foundation, Academy of Athens
Not yet recruiting
Intervention: Drug: Belimumab
Sponsor: Biomedical Research Foundation, Academy of Athens
Not yet recruiting
Pub Date:
Wednesday, September 30, 2020 - 9:00am